Fertility Testing Market is expected to grow significantly over the forecast period. It was valued at USD 420 Million in 2018 and is projected to reach USD 640 Million by 2025, with a CAGR of 7.5% over the forecast period.
The increasing first-time pregnancy age, declining fertility rates across the globe, and the launch of advanced, easy-to-use fertility monitors with high accuracy are likely to provide favorable conditions for the growth of the market during the forecast period.
Various other factors, such as the changing lifestyle and increasing awareness about fertility testing, are also expected to propel the growth of the market.
However, lesser precision of ovulation prediction kits and unproven accuracy of urine-based ovulation monitors in PCOS/PCOD patients might hamper market growth over the forecast period.
Segmentation
The global fertility testing market is segmented based on product, sample, mode of purchase, end user, and region.
The global market for fertility testing, by product, is segmented into ovulation predictor kits, fertility monitors, male fertility testing products, and others.
Based on sample, the global market is segmented into saliva, urine, blood, and others.
Based on mode of purchase, the global market is segmented into prescription-based and OTC-based products.
Based on end user, the global market is segmented into home care settings, hospitals, fertility clinics, and others.
Key Players
Some of the Key Players operating in the Global Fertility Testing Market are TaiDoc Technology Corporation, Church & Dwight Co., Inc., Fairhaven Health, LLC, Fertility Focus Limited, Geratherm Medical AG, HiLin Life Products, Inc., Prestige Brands Holdings, Inc., Quidel Corporation, Babystart Ltd., Swiss Precision Diagnostics GmbH, and Hilin Life Products.
Market Segmentation
Global Fertility Testing Market, by Product
Global Fertility Testing Market, by Sample
Global Fertility Testing Market, by Mode of Purchase
Global Fertility Testing Market, by End User